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Bellevre et al. used D-SPECT (Spectrum Dynamics, Israel) with a cadmium zinc telluride-
based camera for the determination of the heart-to-mediastinum ratio (HMR) of myocardial 
123I-metaiodobenzylguanidine (MIBG) uptake [1]. Since some institutions have changed their 
SPECT equipment from Anger SPECT to D-SPECT for cardiac studies, conventional planar 
images are not available in the routine clinical setting. Although the European Association of 
Nuclear Medicine (EANM) Cardiovascular Committee and the European Council of Nuclear 
Cardiology have recommended the use of medium-energy (ME) collimators for 123I-MIBG 
studies [2], a number of hospitals still use low-energy (LE) collimators, and SPECT MIBG 
HMRs have been added recently. 
While the 123I-MIBG study has been widely used to patients with chronic heart failure and 
Levy body disease, most studies have used planar HMR [3–5]. Whether we can still use the 
previous numerous stock of data and how we can connect the follow-up data in the same 
series of patients are important issues. Considering the exchangeability of data between the 
Anger-type camera and D-SPECT, the authors of this study successfully used an anterior 
view equivalent planogram and introduced a correction formula to standardize the data 
between the two systems [1]. 
We have proposed the use of standardized HMR to the condition obtained with the most 
common ME general purpose collimators for all 123I-MIBG studies irrespective of the 
collimator used in an individual hospital [6, 7]. The conversion coefficient (CC) for the 
mathematical reference value using the most popular ME collimators was CC = 0.88 [7]. 
Therefore, an institutional HMR (HMRi) can be converted to the standard HMR (HMRstd) 
using the following equation: HMRstd = 0.88/CCi × (HMRi − 1) + 1, where CCi is the CC of 
the institutional camera/collimator system. The CC ranged from 0.5 to 1.0 depending on the 
collimator type used [1]. 
However, to extend the standardization of planar HMR to SPECT HMR, conversion between 
SPECT and planar studies again becomes important. We therefore recalculated the data of 
Bellevre et al. [1], assuming a LE high-resolution collimator with a CC of 0.55 (average CC 
of LEHR collimators) [7]. The relationships between D-SPECT HMR, the corrected HMR 
using the correction formula of Bellevre et al. and the standardized HMR based on the 
phantom method using the above equation are shown in  Fig. 1. As found by Bellevre et al. 
[1], the regression line comparing the Anger camera HMR and D-SPECT HMR shows a 
slope of 1.64. After correction using the correction equation of Bellevre et al. the slope 
becomes 0.96 [1]. Based on our proposed conversion to standardized HMR, the slope 
becomes 1.02 with an intercept of −0.13 (Fig. 1c). 
Using the correction D-SPECT HMR +0.1 gives a standardized HMR nearly equal to the 
HMR obtained using the ME collimator (CC 0.88). Since the HMR using the LEHR 
collimator of 1.6, which was used in the ADMIRE-HF study [3], can be converted to 1.9 
using ME collimators, the corresponding dotted lines are shown in Fig. 1d, and indicate good 
concordance between conventional Anger camera and D-SPECT. Before generalizing the 
relationship for HMRs between D-SPECT and Anger camera, we need to know the CC of 
individual institutions and the reproducibility of planogram-based D-SPECT HMR among 
institutions, which might partly depend on preferences as to acquisition and processing 
conditions. However, calibrations between D-SPECT and Anger cameras are promising, and 
all the HMRs, from either planar imaging or SPECT, can be converted to comparable ME 
values as recommended by the EANM Cardiovascular Committee and the European Council 
of Nuclear Cardiology [2]. A larger amount of comparative data are required for validation of 
this method. The phantom-based calibration of HMR has already been performed in Japan in 
approximately 500 hospitals for standardization, and has just been started in some European 
countries. 
Standardization is also important for identifying appropriate thresholds to differentiate good 
and bad prognoses [3–5], as well as for incorporating 123I-MIBG HMR into cardiac 
mortality risk models [8]. This standardization would also help create large databases in 
Europe, North America and Japan. 
Fig. 1 
a, b Linear regression analysis of the relationship between Anger camera HMR and D-
SPECT HMR (a) and between D-SPECT HMR corrected and Anger camera HMR (b) using 
the data of Bellevre et al [1]. c, d Linear regression analysis of the relationship between 
standardized HMR (CC 0.88) and D-SPECT HMR (c) and between D-SPECT HMR + 0.1 
(d). The dotted lines indicate HMR 1.6 and 1.9. The shaded areas denote confidence limits 
for the regression lines 
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